30 closest matches · ranked by relevance
Immunologic Tests
Primary: Number of Subject Responders With Antigen Specific Lymphocytes T Helper 2 (Th2) Cluster of Differentiation 4+ (CD4+) T Cells Expressing Cytokines — 7; 1; 7; 0 Subjects
Blood Component Transfusion
Primary: Number of Participants With Changes in the Production of Antibody to HLA Antigens — 2; 6; 2; 5 Participants
Immunologic Tests
Primary: Frequency of Cluster of Differentiation 4 (CD4) + Forkhead Box p3 (Foxp3) + Expressing CD45RA and/or Human Leucocyte Antigen DR Complex (HLA-DR) and/or Inducible T Cell…
Asthma · Mastocytosis · Mast Cell Activation Syndrome
Primary: Mast Cell Activation Test Results for Validation Group — 6; 2; 0; 4 Participants
Psoriasis
Primary: Change in Percentage of CD4+ T Effector Cells Expressing IL17 Compared to Baseline — -1.42 percent change from week 0
Solid Organ Transplant Recipients · Autoimmune Diseases · Haematological Malignancies
Primary: The Proportion of Participants With and Without Antibodies to SARS-CoV-2 — 875; 378; 277; 1825 Participants
Cutaneous Leishmaniasis
Primary: Sensitizing Effects of LtSTA in Leishmania Naive Adults — 8; 22; 9 participants
Infections After Lung Transplant
Primary: The Primary Outcome Will be the Total Number of Days With Pneumonia. — 1714; 51 Number of days
Upper Respiratory Tract Infections
Primary: Maximal Level of Tumor Necrosis Factor Alpha (pg/ml) — 2694; 2648 tumor necrosis alpha level (pg/ml) — p=.17
History of IgE Dependent Reaction to a Penicillin Product
Primary: Negative Predictive Value — 98.0 percentage of participants
Norovirus · Healthy Participants
Primary: Number of Participants With Serum Samples Obtained on Day 8 for Assessment of Seropositivity for Both Anti-NoV GI.1 VLP and GII.4 VLP Antibodies — 48 participants
Immunosuppression · Kidney Transplantation
Primary: CD4+CD25 High FOXP3+ Cell Levels in Mixed Lymphocyte Reactions (MLRs) of Renal Pre-transplant Recipients/Donors — 90; 85; 25; 50 Percentage of Control Cells
Contact Dermatitis
Primary: Diagnostic Performance: Optimal Test Allergen Concentration — 38.1; 47.6; 52.4; 30.8 percentage of participants
Rhinitis, Allergic, Seasonal
Primary: The Total Number of Differentially Expressed Transcripts. — 119; 49 transcripts
Immunologic Activity Alteration
Primary: Cytokines Profile in Cord Blood Plasma — 1.6; 21.81; 165; 14 pg/ml
Contact Dermatitis
Primary: Diagnostic Performance: Concordance Between Investigational Allergen and Reference Allergen at Day 21 — 78.9 percentage of concordant responses
Influenza
Primary: Count of Participants From Each Arm Who Received Influenza Vaccine — 1; 3; 11; 13 Participants
Allergy to Shrimp · Immunotherapy
Primary: Change in Eliciting Dose of Shrimp During Oral Food Challenge — 3233; 25 mg
Kidney Transplant Rejection · Immunosuppression
Primary: Incidence of Acute Rejection — 0 Participants
Chronic Lung Disease
Primary: Number and Percentage of Participants With Immune Reactivity — 0; 1; 1; 0.0 Participants
Overweight and Obesity
Primary: Weight (kg) — 80; 76.6; 74.7; 75 kilograms
Asthma · Allergic Rhinitis · Atopic Dermatitis
Primary: FcεRI (High Affinity Receptor) Levels at 3 Months — 20.5; 13.66 Positive cells per field
Non-small Cell Lung Cancer Stage I
Primary: Examine the T-cell Receptor Profile Changes Induced in the Tumor After SABR
Diabetes Mellitus, Type 1
Primary: Percentage of Leukocyte Subsets Including B Lymphocytes, Classical B Lymphocytes, Double Negative B Lymphocytes, Naive B Lymphocytes, Plasmablast and Transitional B…
Leprosy
Primary: Number of Participants With Reactions to the Antigen Mycobacterium (M.) Leprae Soluble Antigen (MLSA)-Lipoarabinomannan (LAM) at Doses of 0.1 Microgram — 0; 3; 1; 5…
Allergy · Immune Tolerance · Injection Site Discomfort
Primary: Change in cSMS (Combined Symptom and Medication Score) — 2.6; 2.3; 4.5 score on a scale
Healthy
Primary: Alinity s HBsAg Assay Specificity — 16985; 6; 2 Participants
Allergic Contact Dermatitis
Primary: Number of Participants With Negative, Positive, Irritant or Doubtful Reaction Scores — 49; 3; 0; 1 Participants
Psoriasis
Primary: Change in Psoriasis Area and Severity Index (PASI) Score — 13.92; 4.43 units on a scale — p=0.38
Allergic Rhinitis · Asthma · Food Allergy
Primary: Wheal Response — 6.8 mm